[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369592-105":59,"doc-detail-369592-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cystathionine-gamma-lyase-mediated-hypoxia-inducible-factor-1-alpha-expression-drives-clear-cell-ovarian-cancer-progression","Cystathionine gamma-lyase-mediated hypoxia inducible factor 1-alpha expression drives clear cell ovarian cancer progression","","Clear cell ovarian cancer (CCOC) is the second most common ovarian cancer subtype and is linked to poor outcomes, strong chemoresistance, prominent hypoxic signaling, and abundant cystathionine gamma-lyase (CTH) expression. Using molecular tools and cancer models, CTH expression was shown to rise under stressors including hypoxic conditions and exposure to endometriotic cyst content, supporting survival and a differentiation program associated with aggressive CCOC behavior. Mechanistically, CTH enhances HIF1α independently of H2S and CTH/HIF1α restoration reinstates metastatic capacity in vivo. Therapeutic CTH targeting reduces metastasis and improves chemotherapy sensitivity, highlighting CTH as a defining feature and drug target.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cystathionine-gamma-lyase-mediated-hypoxia-inducible-factor-1-alpha-expression-drives-clear-cell-ovarian-cancer-progression/369592/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cystathionine-gamma-lyase-mediated-hypoxia-inducible-factor-1-alpha-expression-drives-clear-cell-ovarian-cancer-progression/369592.png","ImageObject",300,407,{"name":92,"@type":93},"Fahsai","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is CTH and why is it important in clear cell ovarian cancer?","Question",{"text":112,"@type":113},"CTH (cystathionine gamma-lyase) is highly expressed in clear cell ovarian cancer and supports key programs linked to survival, redox control, and aggressive progression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does CTH affect hypoxia signaling in the study?",{"text":117,"@type":113},"CTH enhances hypoxia inducible factor 1-alpha (HIF1α) expression independently of hydrogen sulfide (H2S) production, and re-expression of HIF1α restores metastatic capacity in vivo.",{"name":119,"@type":110,"acceptedAnswer":120},"What therapeutic effect did CTH targeting show?",{"text":121,"@type":113},"Targeting CTH in clear cell ovarian cancer significantly reduced metastatic potential in in vivo models and increased sensitivity to chemotherapy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369592,1790318905,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},549768702563,"https://ap-avatar.wpscdn.com/avatar/8000c4aa63b76e948b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786536092046926083","Journal of Pathology  \nJ Pathol July 2025; 266: 352–367  \nPublished online 15 May 2025 in Wiley Online Library (wi[leyonlinelibrary.com](leyonlinelibrary.com) DOI: 10.1002/path.6433)[)](leyonlinelibrary.com) DOI: 10.1002/path.6433)[ DOI:](leyonlinelibrary.com) DOI: 10.1002/path.6433)[ 10.1002/path.6433](leyonlinelibrary.com) DOI: 10.1002/path.6433)  \nORIGINAL ARTICLE  \nCystathionine gamma-lyase-mediated hypoxia inducible factor 1-alpha expression drives clear cell ovarian cancer progression  \nAmal M EL-Naggar 1,2,3, Yuqin Li 1,2, Busra Turgu 1,2, Yuchen Ding 1,2, Longyijie Wei 1 , Shary Yuting Chen 1 , Genny Trigo-Gonzalez 1 , Forouh Kalantari 1 , Rodrigo Vallejos 1 , Branden Lynch 1 , Janine Senz 1 , Amy Lum 1 , J Maxwell Douglas 1 , Clara Salamanca 1 , Shelby Thornton4, Yimei Qin4, Kiran Parmar5, Sandra E Spencer6, Samuel Leung7, Michelle MM Woo8,9, Paul J Yong5,8, Hai-Feng Zhang 1,2, Christopher S Hughes 10, Gian Luca Negri6, Yemin Wang 1,2, Gregg B Morin6,11 , Poul H Sorensen 1,2 and David G Huntsman 1,2,4,7,8,9,11 *  \n1 Department of Molecular Oncology, BC Cancer Research Institute, Vancouver, BC, Canada  \n2 Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada  \n3 Department of Pathology, Faculty of Medicine, Menouﬁa University, Shibin El Kom, Egypt  \n4 Molecular and Advanced Pathology Core (MAPCore), University of British Columbia, Vancouver, BC, Canada  \n5 BC Centre for Pelvic Pain and Endometriosis, BC Women ’s Hospital, Vancouver, BC, Canada  \n6 Michael Smith Genome Sciences Centre, BC Cancer Research Institute, Vancouver, BC, Canada  \n7 Genetic Pathology Evaluation Centre, Vancouver, BC, Canada  \n8 Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada  \n9 BC’s Gynecologic Cancer Research Program, OVCARE, Vancouver, BC, Canada  \n10 Department of Medicine, Dalhousie University, Halifax, NS, Canada  \n11 Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada  \n*Correspondence to: DG Huntsman, 675 West 10 Avenue, Vancouver, BC V5Z 1L3, Canada. E-mail: dhuntsma@bccancer.bc.ca  \nAbstract  \nClear cell ovarian cancer (CCOC) is the second most common ovarian cancer subtype, accounting for 5%–11% of ovarian cancers in North America. Late-stage CCOC is associated with a worse prognosis compared to other ovarian cancer histotypes, a challenge that has seen limited progress in recent decades. CCOC typically originates within the toxic microenvironment of endometriotic ovarian cysts and is characterized by its intrinsic chemoresistance, a strong hypoxic signature, and abundant expression of cystathionine gamma-lyase (CTH). CTH is a key enzyme in the transsulfuration pathway and serves as a marker of ciliated cells derived from the Müllerian tract. CTH plays a pivotal role inde novo cysteine synthesis, which is essential for glutathione (GSH) production and redox homeostasis.  \nUsing an array of molecular tools and cancer models, including in vivo studies, we demonstrated that CTH expression  \nwas induced under various stress conditions, such as exposure to endometriotic cyst content and hypoxia. This induction enables cell survival and creates a differentiation state manifested by CCOC that potentiates tumor progression and metastasis. In addition to regulating redox homeostasis, CTH enhances hypoxia inducible factor 1-alpha (HIF1α) expression, independently of hydrogen sulﬁde (H2S) production. Re-expression of HIF1α in CTH KO cells fully restored metastatic capacity in in vivo models. Co-expression of CTH and HIF1α proteins was also observed in human CCOC samples. Importantly, targeting CTH in CCOC signiﬁcantly reduced its metastatic potential in in vivo models and enhanced sensitivity to chemotherapy. These ﬁndings underscore that CTH is both a deﬁning feature of CCOC and a promising therapeutic target, not only for CCOC patients but also for those with other CTH-expressing cancers.  \n© 2025 The Author(s). The","cbCaimI6sKmr2Xps","https://ap.wps.com/l/cbCaimI6sKmr2Xps","pdf",30444677,16,"English","# Abstract\n# Introduction\n## Background on CCOC prevalence and prognosis\n## Genetic and molecular features of CCOC\n## Cellular lineage associations and endometrial similarity","[{\"question\":\"What is CTH and why is it important in clear cell ovarian cancer?\",\"answer\":\"CTH (cystathionine gamma-lyase) is highly expressed in clear cell ovarian cancer and supports key programs linked to survival, redox control, and aggressive progression.\"},{\"question\":\"How does CTH affect hypoxia signaling in the study?\",\"answer\":\"CTH enhances hypoxia inducible factor 1-alpha (HIF1α) expression independently of hydrogen sulfide (H2S) production, and re-expression of HIF1α restores metastatic capacity in vivo.\"},{\"question\":\"What therapeutic effect did CTH targeting show?\",\"answer\":\"Targeting CTH in clear cell ovarian cancer significantly reduced metastatic potential in in vivo models and increased sensitivity to chemotherapy.\"}]","Cystathionine gamma-lyase-mediated hypoxia inducible factor 1-alpha expression drives clear cell ovarian cancer progression | PDF",1790183586,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2b09815fe09d857faffd025c842a485f.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/af8a3003491d1bf20aa73aa8b36f4008.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3f9744ba87e0815a4ac9ef80a1f6f46f.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/526b5e6ba55b03a2781ed901c68d714e.webp",980,1385]